Your browser doesn't support javascript.
loading
Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians.
Molineros, Julio E; Looger, Loren L; Kim, Kwangwoo; Okada, Yukinori; Terao, Chikashi; Sun, Celi; Zhou, Xu-Jie; Raj, Prithvi; Kochi, Yuta; Suzuki, Akari; Akizuki, Shuji; Nakabo, Shuichiro; Bang, So-Young; Lee, Hye-Soon; Kang, Young Mo; Suh, Chang-Hee; Chung, Won Tae; Park, Yong-Beom; Choe, Jung-Yoon; Shim, Seung-Cheol; Lee, Shin-Seok; Zuo, Xiaoxia; Yamamoto, Kazuhiko; Li, Quan-Zhen; Shen, Nan; Porter, Lauren L; Harley, John B; Chua, Kek Heng; Zhang, Hong; Wakeland, Edward K; Tsao, Betty P; Bae, Sang-Cheol; Nath, Swapan K.
Affiliation
  • Molineros JE; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • Looger LL; Howard Hughes Medical Institute, Janelia Research Campus, Ashburn, Virginia, United States of America.
  • Kim K; Department of Biology, Kyung Hee University, Seoul, Republic of Korea.
  • Okada Y; Department of Statistical Genetics, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Terao C; Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Sun C; Laboratory of Statistical Immunology, Immunology Frontier Research Center (WPI-IFReC), Osaka University, Suita, Japan.
  • Zhou XJ; Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Raj P; Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto, Japan.
  • Kochi Y; Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Suzuki A; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America.
  • Akizuki S; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
  • Nakabo S; Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.
  • Bang SY; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.
  • Lee HS; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
  • Kang YM; Laboratory for Autoimmune Diseases, Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
  • Suh CH; Laboratory for Autoimmune Diseases, Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
  • Chung WT; Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Park YB; Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Choe JY; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.
  • Shim SC; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.
  • Lee SS; School of Medicine, Kyungpook National University Hospital, Daegu, Korea.
  • Zuo X; Department of Rheumatology, Ajou University Hospital, Suwon, Korea.
  • Yamamoto K; Dong-A University Hospital, Department of Internal Medicine, Busan, Korea.
  • Li QZ; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Shen N; Department of Rheumatology, Catholic University of Daegu School of Medicine, Daegu, Korea.
  • Porter LL; Daejeon Rheumatoid & Degenerative Arthritis Center, Chungnam National University Hospital, Daejeon, Korea.
  • Harley JB; Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea.
  • Chua KH; Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha, China.
  • Zhang H; Laboratory for Autoimmune Diseases, Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
  • Wakeland EK; Department of Immunology and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
  • Tsao BP; Department of Rheumatology and Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Bae SC; Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Nath SK; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.
PLoS Genet ; 15(4): e1008092, 2019 04.
Article in En | MEDLINE | ID: mdl-31022184
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Histocompatibility Antigens Class I / Histocompatibility Antigens Class II / Amino Acid Sequence / Disease Susceptibility / Lupus Erythematosus, Systemic Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: PLoS Genet Journal subject: GENETICA Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Histocompatibility Antigens Class I / Histocompatibility Antigens Class II / Amino Acid Sequence / Disease Susceptibility / Lupus Erythematosus, Systemic Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: PLoS Genet Journal subject: GENETICA Year: 2019 Document type: Article Affiliation country: Country of publication: